As expected, leptin‐induced ATP production was significantly inhibited by cotreatment with Etomoxir (Fig. 1G), suggesting that leptin uses fatty acid (FFA) for ATP production in breast cancer cells. The gene discussed is LEP; the disease is breast cancer.